356 related articles for article (PubMed ID: 24039759)
21. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
[TBL] [Abstract][Full Text] [Related]
22. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
[TBL] [Abstract][Full Text] [Related]
23. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
24. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
[TBL] [Abstract][Full Text] [Related]
26. Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
Hadjialirezaei S; Picco G; Beatson R; Burchell J; Stokke BT; Sletmoen M
PLoS One; 2017; 12(4):e0175323. PubMed ID: 28414807
[TBL] [Abstract][Full Text] [Related]
27. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
28. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.
Ricardo S; Marcos-Silva L; Pereira D; Pinto R; Almeida R; Söderberg O; Mandel U; Clausen H; Felix A; Lunet N; David L
Mol Oncol; 2015 Feb; 9(2):503-12. PubMed ID: 25454345
[TBL] [Abstract][Full Text] [Related]
29. The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.
Ho CW; Lin CY; Liaw YW; Chiang HL; Chin YT; Huang RL; Lai HC; Hsu YW; Kuo PJ; Chen CE; Lin HY; Whang-Peng J; Nieh S; Fu E; Liu LF; Hwang J
Oncotarget; 2016 Sep; 7(38):61930-61944. PubMed ID: 27542280
[TBL] [Abstract][Full Text] [Related]
30. Cosmc-dependent mucin-type
Stotter BR; Talbot BE; Capen DE; Artelt N; Zeng J; Matsumoto Y; Endlich N; Cummings RD; Schlondorff JS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F518-F530. PubMed ID: 31904283
[TBL] [Abstract][Full Text] [Related]
31. Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.
Ju T; Wang Y; Aryal RP; Lehoux SD; Ding X; Kudelka MR; Cutler C; Zeng J; Wang J; Sun X; Heimburg-Molinaro J; Smith DF; Cummings RD
Proteomics Clin Appl; 2013 Oct; 7(9-10):618-31. PubMed ID: 23857728
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
33. CD44-Associated Tn Antigen as a New Biomarker of Tumor Cells with Aberrant Glycosylation.
Shuvalova ML; Kopylov AT; Mazurov DV; Pichugin AV; Bovin NV; Filatov AV
Biochemistry (Mosc); 2020 Sep; 85(9):1064-1081. PubMed ID: 33050853
[TBL] [Abstract][Full Text] [Related]
34. Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
Hong JC; Kim YS
Glycoconj J; 2000 Oct; 17(10):691-703. PubMed ID: 11425189
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylation.
Rømer TB; Khoder-Agha F; Aasted MKM; de Haan N; Horn S; Dylander A; Zhang T; Pallesen EMH; Dabelsteen S; Wuhrer M; Høgsbro CF; Thomsen EA; Mikkelsen JG; Wandall HH
Glycobiology; 2023 Oct; 33(9):700-714. PubMed ID: 36648436
[TBL] [Abstract][Full Text] [Related]
36. The Tn antigen-structural simplicity and biological complexity.
Ju T; Otto VI; Cummings RD
Angew Chem Int Ed Engl; 2011 Feb; 50(8):1770-91. PubMed ID: 21259410
[TBL] [Abstract][Full Text] [Related]
37. Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
Haugstad KE; Stokke BT; Brewer CF; Gerken TA; Sletmoen M
Glycobiology; 2015 May; 25(5):524-34. PubMed ID: 25527429
[TBL] [Abstract][Full Text] [Related]
38. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.
Lloyd KO; Burchell J; Kudryashov V; Yin BW; Taylor-Papadimitriou J
J Biol Chem; 1996 Dec; 271(52):33325-34. PubMed ID: 8969192
[TBL] [Abstract][Full Text] [Related]
39. The Role of Sialyl-Tn in Cancer.
Munkley J
Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
[TBL] [Abstract][Full Text] [Related]
40. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]